Harvest Fund Management Co. Ltd Grows Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Harvest Fund Management Co. Ltd boosted its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 198.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 26,889 shares of the company's stock after buying an additional 17,869 shares during the period. Harvest Fund Management Co. Ltd's holdings in Doximity were worth $1,435,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of DOCS. KBC Group NV boosted its stake in Doximity by 22.9% during the third quarter. KBC Group NV now owns 3,296 shares of the company's stock worth $144,000 after buying an additional 614 shares during the period. Natixis Advisors LLC boosted its stake in shares of Doximity by 43.5% during the third quarter. Natixis Advisors LLC now owns 31,815 shares of the company's stock valued at $1,386,000 after purchasing an additional 9,644 shares during the period. Thrivent Financial for Lutherans increased its stake in Doximity by 5.0% in the 3rd quarter. Thrivent Financial for Lutherans now owns 30,991 shares of the company's stock worth $1,350,000 after buying an additional 1,474 shares during the period. Prospera Private Wealth LLC purchased a new stake in Doximity in the 3rd quarter valued at about $133,000. Finally, Commerce Bank purchased a new position in shares of Doximity during the third quarter worth approximately $314,000. Institutional investors own 87.19% of the company's stock.

Insider Transactions at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the business's stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares in the company, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 37.40% of the company's stock.

Remove Ads

Analyst Ratings Changes

DOCS has been the topic of several recent research reports. Mizuho increased their target price on shares of Doximity from $55.00 to $65.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. The Goldman Sachs Group lifted their target price on Doximity from $58.00 to $80.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Leerink Partners raised shares of Doximity from a "market perform" rating to an "outperform" rating and increased their price target for the company from $60.00 to $90.00 in a research report on Friday, February 7th. Piper Sandler upgraded shares of Doximity from a "neutral" rating to an "overweight" rating and boosted their price objective for the stock from $31.00 to $78.00 in a research note on Friday, February 7th. Finally, Raymond James reiterated an "outperform" rating and set a $83.00 price objective (up previously from $65.00) on shares of Doximity in a report on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $64.22.

Doximity Stock Up 5.4 %

NASDAQ DOCS traded up $3.40 on Monday, reaching $66.39. The stock had a trading volume of 3,877,772 shares, compared to its average volume of 1,891,425. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21. The stock has a fifty day moving average price of $64.42 and a two-hundred day moving average price of $53.63. The firm has a market capitalization of $12.39 billion, a price-to-earnings ratio of 66.39, a P/E/G ratio of 4.10 and a beta of 1.34.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.